SlideShare uma empresa Scribd logo
1 de 38
A Comparison of Ratios Of Ferozsons Lab. Ltd and Searle Pakistan Ltd . Group members Farheen Khalid Nissa Razzak Sobia Yousuf Lubna Mahar
INTRODUCTION TO FEROZSONS
COMPANY PROFILE Exchanges:   Karachi, Lahore & Islamabad Symbol:   Feroz Country:   Pakistan City:   Rawalpindi Industry:   The company is primarily engaged in the manufacturing and sale of pharmaceuticals and soap products   Number of Employees:   461 Year Ended:   30th June
INTRODUCTION TO SEARLE
COMPANY PROFILE Exchanges:   Karachi & Islamabad Symbol:   Searl Country:   Pakistan City:   Karachi Industry:   The company is principally engaged in the manufacture of pharmaceutical products and a low calories sweetener  Number of Employees:   528 Year Ended:   30th June
FINANCIAL RATIOS 2004 & 2005
LIQUIDITY RATIOS
CURRENT RATIO Current Ratio= Current Assets Current Liabilities 1.22 2.82 2005  1.11 2.01 2004 Searle Ferozsons   Year
QUICK RATIO (ACID-TEST RATIO) Quick Ratio= Current Asset-Inventory Current Liabilities 0.96 1.01 2005 0.97 1.89 2004 Searle Ferozsons Year
LEVERAGE RATIOS
DEBT TO EQUITY RATIO Debt-to-Equity=  Total Debt Shareholder Equity 2 0.36 2005 3 0.46 2004 Searle Ferozsons Year
DEBT TO TOTAL ASSETS Total Debt Ratio=   Total Debt Total Assets 0.56 0.24 2005 0.52 0.27 2004 Searle Ferozsons Year
EQUITY MULTIPLIER Equity Multiplier=  Total Assets Shareholders’ equity 3.55 1.5 2005 4.55 1.71 2004 Searle Ferozsons Year
COVERAGE RATIO
TIMES INTEREST EARNED Times Interest Earned=  EBIT Interest Charges 4.5 118 2005 3.9 104.5 2004 Searle Ferozsons Year
EFFICIENCY RATIOS
RECEIVABLE TURNOVER Receivable Turnover=  Annual Net Credit Sales Receivables 3.07 87 2005 2.8 64.5   2004 Searle Ferozsons Year
RECEIVABLE TUROVER IN DAYS Average collection period=  Days in a year Receivable Turnover 117 4 2005 129 6 2004 Searle Ferozsons Year
INVENTORY TURNOVER Inventory Turnover =  Cost Of Goods Sold Inventory 6.4 3.6 2005 5.45 3.5 2004 Searle Ferozsons Year
INVENTORY TURNOVER IN DAYS Inventory Turnover in Days=  Days in a year   Inventory turnover 56 101 2005 66 103 2004 Searle Ferozsons Year
TOTAL ASSET TURNOVER Total Asset Turnover=  Net sales Total assets 1.04 1.27 2005 0.93 1.53 2004 Searle Ferozsons Year
PROFITABILITY RATIOS
GROSS PROFIT MARGIN Gross Profit Margin= Gross Profit Net Sales 32.5% 53% 2005 37% 50% 2004 Searle Ferozsons Year
NET PROFIT MARGIN Net Profit Margin= Net profit after taxes   Net sales 3.50% 21% 2005 6% 16% 2004 Searle   Ferozsons Year
RETURN ON ASSETS Return on Assets=  Net profit after taxes Total assets 3.70% 27% 2005 5% 24% 2004 Searle Ferozsons Year
RETURN ON ASSETS DUPONT APPROACH Return on Assets= Net profit margin*Total Asset Turnover 0.036 0.26 2005 0.055 0.24 2004 Searle Ferozsons Year
RETURN ON EQUITY Return on Equity=  Net profit after taxes Shareholder’s equity 13.10% 41% 2005 24% 42% 2004 Searle Ferozsons Year
RETURN ON EQUITY DUPONT APPROACH Return on Equity = Net profit margin*Total Asset Turnover*Equity Multiplier 0.13 0.40 2005 0.25 0.41 2004 Searle Ferozsons Year
MARKET VALUE  MEASURES
EARNINGS PER SHARE EARNING PER SHARE=  EAT No. Of Shares 3.6 19.87 2005 5.06 13.06 2004 Searle Ferozsons Year
PRICE TO EARNINGS SHARE Price to Earnings Ratio=  Price Earnings 11.56 9.30 2005 6.92 9.47 2004 Searle Ferozsons Year
Common Size & Indexed Size Balance Sheet & Income Statement
FEROZSONS’ COMMON & INDEXED SIZE BALANCE SHEET (ASSET SIDE) 72.16 100.00 100.00 100.00 575305163 415130035 TOTAL 60.19 100.00 53.19 44.37 306002950 184183116 TOTAL CURRENT ASSETS 56.74 100.00 14.44 11.35 83045347 47119395 Cash and bank balances 43.39 100.00 9.92 5.97 57071000 24763787 short term investments 54.83 100.00 1.08 0.82 6206514 3403035 Trade deposits 117.42 100.00 1.46 2.38 8415508 9881645 Trade debts (RECEIVABLES) 90.49 100.00 17.48 21.92 100545997 90984280 Stocks-in-trade 116.6  100.00 46.81 55.63 269302213 230946919 TOTAL FIXED ASSETS 100.58 100.00 0.09 0.13 538147 541247 LONG TERM DEPOSITS 100.00 100.00 0.01 0.01 33085 33085 LONG TERM INVESTMENTS 85.73 100.00 46.71 55.49 268730981 230372587 Property, plant & equipment             Fixed Assets Tangible Indexed size % Common size % Regular Years   2005 2004 2005 2004 2005 2004  
FEROZSONS’ COMMON & INDEXED SIZE BALANCE SHEET  (LIABILITY SIDE) 138.58 100.00 100.00 100.00 575305163 415130035 TOTAL LIABILITY AND EQUITY 123.26 100.00 23.80 26.76 136906815 111075514 Total liabilities 118.58 100.00 18.86 22.05 108520915 91519724   Total Current Liabilities 139.96 100.00 12.50 12.38 71912416 51381311 Trade and other payables             Current Liabilities 145.15 100.00 4.93 4.71 28385900 19555790   Total Non Current Liabilities 158.15 100.00 66.66 58.41 383470795 242479041   Total Equity Indexed Size% Common Size% Regular Years 2005 2004 2005 2004 2005 2004  
FEROZSONS’COMMON & INDEXED SIZE INCOME SHEET   152.11 100.00 21.03 15.84 153565799 100955403 Net profit 152.31 100.00 21.05 15.83 153664442 100891537 Profit after taxes 131.50 100.00 8.71 7.59 63607622 48371149 Profit for taxation 145.56 100.00 29.76 23.41 217272064 149262686 Earning after interest 128.62 100.00 0.25 0.23 1854323 1441689 Finance Cost 145.40 100.00 30.01 23.64 219126387 150704375 EBIT 461.44 100.00 3.55 0.88 25929235 5619173 Other income 136.65 100.00 28.96 24.27 211392190 154698493 Operating profit 107.61 100.00 24.22 25.78 176837384 164335764 total expenses 104.28 100.00 19.54 21.46 142663053 136807554 selling & distribution costs 124.14 100.00 4.68 4.32 34174331 27528210 Administrative Expenses 121.69 100.00 53.18 50.05 388229574 319034257 Gross profit 107.35 100.00 46.82 49.95 341837087 318441195 Cost of goods sold 114.52 100.00 100.00 100.00 730066661 637475452 Net sales 2005 2004 2005 2004 2005 2004   Indexed Size% Common Size% Regular Year  
[object Object],[object Object],[object Object],[object Object],RECOMMENDATIONS
[object Object],[object Object],[object Object],[object Object],CONCLUSION
QUESTIONS TIME

Mais conteúdo relacionado

Mais procurados

Shilpa Medicare: Buy for medium to long term investment
Shilpa Medicare: Buy for medium to long term investmentShilpa Medicare: Buy for medium to long term investment
Shilpa Medicare: Buy for medium to long term investmentIndiaNotes.com
 
Coca-Cola 2016 Financial Analysis (Half year ended 30 June)
Coca-Cola 2016 Financial Analysis (Half year ended 30 June)Coca-Cola 2016 Financial Analysis (Half year ended 30 June)
Coca-Cola 2016 Financial Analysis (Half year ended 30 June)VCE Accounting - Michael Allison
 
Pepsi & Coca Cola Financial Analysis
Pepsi & Coca Cola Financial AnalysisPepsi & Coca Cola Financial Analysis
Pepsi & Coca Cola Financial AnalysisHassan Shahzad
 
Comparative statement of reliance industries ltd
Comparative statement of reliance industries ltdComparative statement of reliance industries ltd
Comparative statement of reliance industries ltdvijay jha
 
Di Bacco Brochure Services PowerPoint
Di Bacco Brochure Services PowerPointDi Bacco Brochure Services PowerPoint
Di Bacco Brochure Services PowerPointJoe Mcgough
 

Mais procurados (9)

Shilpa Medicare: Buy for medium to long term investment
Shilpa Medicare: Buy for medium to long term investmentShilpa Medicare: Buy for medium to long term investment
Shilpa Medicare: Buy for medium to long term investment
 
Financial management term project
Financial management term projectFinancial management term project
Financial management term project
 
Coca-Cola 2016 Financial Analysis (Half year ended 30 June)
Coca-Cola 2016 Financial Analysis (Half year ended 30 June)Coca-Cola 2016 Financial Analysis (Half year ended 30 June)
Coca-Cola 2016 Financial Analysis (Half year ended 30 June)
 
Larsen & toubro.ppt_25
Larsen & toubro.ppt_25Larsen & toubro.ppt_25
Larsen & toubro.ppt_25
 
Pepsi & Coca Cola Financial Analysis
Pepsi & Coca Cola Financial AnalysisPepsi & Coca Cola Financial Analysis
Pepsi & Coca Cola Financial Analysis
 
Comparative statement of reliance industries ltd
Comparative statement of reliance industries ltdComparative statement of reliance industries ltd
Comparative statement of reliance industries ltd
 
Di Bacco Brochure Services PowerPoint
Di Bacco Brochure Services PowerPointDi Bacco Brochure Services PowerPoint
Di Bacco Brochure Services PowerPoint
 
ATS Company Reports: Eclerx
ATS Company Reports: EclerxATS Company Reports: Eclerx
ATS Company Reports: Eclerx
 
Afm
Afm Afm
Afm
 

Destaque

Analysis On Financial Statement Of Pharmaceutical Co. In Pakistan
Analysis On Financial Statement Of Pharmaceutical  Co. In PakistanAnalysis On Financial Statement Of Pharmaceutical  Co. In Pakistan
Analysis On Financial Statement Of Pharmaceutical Co. In PakistanImad Baig
 
Presentation of the iv International Economic Business Congress
Presentation of the iv International Economic Business CongressPresentation of the iv International Economic Business Congress
Presentation of the iv International Economic Business CongressОльга Бухта
 
Analysis of financial statement of pharma industry
Analysis of financial statement of pharma industryAnalysis of financial statement of pharma industry
Analysis of financial statement of pharma industrygohar Iqbal
 
Pakistan Pharmaceutical Market Overview (2015)
Pakistan Pharmaceutical Market Overview (2015)Pakistan Pharmaceutical Market Overview (2015)
Pakistan Pharmaceutical Market Overview (2015)Muhammad Ali Jehangir
 
Principles Of Marketing 1
Principles Of  Marketing 1Principles Of  Marketing 1
Principles Of Marketing 1ali.jibran
 
pharmaceutical industry of pakistan
pharmaceutical industry of pakistanpharmaceutical industry of pakistan
pharmaceutical industry of pakistanNaushii Khan
 
Pharmaceutical industry of pakistan
Pharmaceutical industry of pakistan Pharmaceutical industry of pakistan
Pharmaceutical industry of pakistan Naushii Khan
 

Destaque (8)

Analysis On Financial Statement Of Pharmaceutical Co. In Pakistan
Analysis On Financial Statement Of Pharmaceutical  Co. In PakistanAnalysis On Financial Statement Of Pharmaceutical  Co. In Pakistan
Analysis On Financial Statement Of Pharmaceutical Co. In Pakistan
 
Presentation of the iv International Economic Business Congress
Presentation of the iv International Economic Business CongressPresentation of the iv International Economic Business Congress
Presentation of the iv International Economic Business Congress
 
Ibf ppt
Ibf pptIbf ppt
Ibf ppt
 
Analysis of financial statement of pharma industry
Analysis of financial statement of pharma industryAnalysis of financial statement of pharma industry
Analysis of financial statement of pharma industry
 
Pakistan Pharmaceutical Market Overview (2015)
Pakistan Pharmaceutical Market Overview (2015)Pakistan Pharmaceutical Market Overview (2015)
Pakistan Pharmaceutical Market Overview (2015)
 
Principles Of Marketing 1
Principles Of  Marketing 1Principles Of  Marketing 1
Principles Of Marketing 1
 
pharmaceutical industry of pakistan
pharmaceutical industry of pakistanpharmaceutical industry of pakistan
pharmaceutical industry of pakistan
 
Pharmaceutical industry of pakistan
Pharmaceutical industry of pakistan Pharmaceutical industry of pakistan
Pharmaceutical industry of pakistan
 

Semelhante a IBF final presentation

All financial ratios of bata shoe of last five years
All financial ratios of bata shoe of last five years All financial ratios of bata shoe of last five years
All financial ratios of bata shoe of last five years Faiz Subhani
 
Novartis and IPCA Financial Analysis
Novartis and IPCA Financial AnalysisNovartis and IPCA Financial Analysis
Novartis and IPCA Financial AnalysisShahzad Khan
 
Sitara chemical by Muhammad Waqar
Sitara chemical by Muhammad WaqarSitara chemical by Muhammad Waqar
Sitara chemical by Muhammad WaqarMuhammad Waqar
 
Financial Analysis 3.pptx
Financial Analysis 3.pptxFinancial Analysis 3.pptx
Financial Analysis 3.pptxNadeemSRimawi
 
Financial statement analysis.pptx
Financial statement analysis.pptxFinancial statement analysis.pptx
Financial statement analysis.pptxziarehman95
 
Account as a decession making tool for qs
Account as a decession making tool for qsAccount as a decession making tool for qs
Account as a decession making tool for qsanojan kanagarathnam
 
Tofas Financial Accounting
Tofas Financial AccountingTofas Financial Accounting
Tofas Financial AccountingMert Ucmer
 
PSO Finance Presentation
PSO Finance PresentationPSO Finance Presentation
PSO Finance Presentationshafiqabdullah
 
MK Restaurant Finance of 2015 - 2016
MK Restaurant Finance of 2015 - 2016MK Restaurant Finance of 2015 - 2016
MK Restaurant Finance of 2015 - 2016Shooger
 
Financial Analysis of the Financial Ratios of Indian Oil Corporation Ltd.
Financial Analysis of the Financial Ratios of Indian Oil Corporation Ltd.Financial Analysis of the Financial Ratios of Indian Oil Corporation Ltd.
Financial Analysis of the Financial Ratios of Indian Oil Corporation Ltd.Mohammad Mohtashim
 
Analysis of voltas reports 2014
Analysis of voltas reports 2014Analysis of voltas reports 2014
Analysis of voltas reports 2014Harsh Vardhan
 
Ratio analysis of Unilever
Ratio analysis of UnileverRatio analysis of Unilever
Ratio analysis of UnileverNasir Ali
 
Finanical Accouting Auditing report
Finanical Accouting Auditing report Finanical Accouting Auditing report
Finanical Accouting Auditing report nadaomarmohamed
 

Semelhante a IBF final presentation (20)

D DuPont analysis
D DuPont analysisD DuPont analysis
D DuPont analysis
 
All financial ratios of bata shoe of last five years
All financial ratios of bata shoe of last five years All financial ratios of bata shoe of last five years
All financial ratios of bata shoe of last five years
 
Novartis and IPCA Financial Analysis
Novartis and IPCA Financial AnalysisNovartis and IPCA Financial Analysis
Novartis and IPCA Financial Analysis
 
Sitara chemical by Muhammad Waqar
Sitara chemical by Muhammad WaqarSitara chemical by Muhammad Waqar
Sitara chemical by Muhammad Waqar
 
Financial Analysis 3.pptx
Financial Analysis 3.pptxFinancial Analysis 3.pptx
Financial Analysis 3.pptx
 
Financial statement analysis.pptx
Financial statement analysis.pptxFinancial statement analysis.pptx
Financial statement analysis.pptx
 
Account as a decession making tool for qs
Account as a decession making tool for qsAccount as a decession making tool for qs
Account as a decession making tool for qs
 
Tofas Financial Accounting
Tofas Financial AccountingTofas Financial Accounting
Tofas Financial Accounting
 
PSO Finance Presentation
PSO Finance PresentationPSO Finance Presentation
PSO Finance Presentation
 
MK Restaurant Finance of 2015 - 2016
MK Restaurant Finance of 2015 - 2016MK Restaurant Finance of 2015 - 2016
MK Restaurant Finance of 2015 - 2016
 
Financial Analysis of the Financial Ratios of Indian Oil Corporation Ltd.
Financial Analysis of the Financial Ratios of Indian Oil Corporation Ltd.Financial Analysis of the Financial Ratios of Indian Oil Corporation Ltd.
Financial Analysis of the Financial Ratios of Indian Oil Corporation Ltd.
 
FINANCIAL ANALYSIS OF NOVARTIS INDIA
FINANCIAL ANALYSIS OF NOVARTIS INDIAFINANCIAL ANALYSIS OF NOVARTIS INDIA
FINANCIAL ANALYSIS OF NOVARTIS INDIA
 
Seplat
SeplatSeplat
Seplat
 
SEPLAT
SEPLATSEPLAT
SEPLAT
 
Seplat
SeplatSeplat
Seplat
 
Analysis of voltas reports 2014
Analysis of voltas reports 2014Analysis of voltas reports 2014
Analysis of voltas reports 2014
 
Ratio analysis
Ratio analysisRatio analysis
Ratio analysis
 
Ratio analysis of Unilever
Ratio analysis of UnileverRatio analysis of Unilever
Ratio analysis of Unilever
 
FIN Chapter 4.ppt
FIN  Chapter 4.pptFIN  Chapter 4.ppt
FIN Chapter 4.ppt
 
Finanical Accouting Auditing report
Finanical Accouting Auditing report Finanical Accouting Auditing report
Finanical Accouting Auditing report
 

Mais de Nyssa Razzak

Understanding the oil business PSO
Understanding the oil business PSOUnderstanding the oil business PSO
Understanding the oil business PSONyssa Razzak
 
Jingles All The Way1
Jingles All The Way1Jingles All The Way1
Jingles All The Way1Nyssa Razzak
 
Jingles All The Way
Jingles All The WayJingles All The Way
Jingles All The WayNyssa Razzak
 
Total Quality Management
Total Quality ManagementTotal Quality Management
Total Quality ManagementNyssa Razzak
 
Services Marketing
Services MarketingServices Marketing
Services MarketingNyssa Razzak
 
Strategic Marketing & Planning
Strategic Marketing & PlanningStrategic Marketing & Planning
Strategic Marketing & PlanningNyssa Razzak
 
Shield Imc presentation
Shield Imc presentationShield Imc presentation
Shield Imc presentationNyssa Razzak
 

Mais de Nyssa Razzak (10)

Understanding the oil business PSO
Understanding the oil business PSOUnderstanding the oil business PSO
Understanding the oil business PSO
 
Jingles All The Way1
Jingles All The Way1Jingles All The Way1
Jingles All The Way1
 
Jingles All The Way
Jingles All The WayJingles All The Way
Jingles All The Way
 
Total Quality Management
Total Quality ManagementTotal Quality Management
Total Quality Management
 
Media Planning
Media PlanningMedia Planning
Media Planning
 
Services Marketing
Services MarketingServices Marketing
Services Marketing
 
My Brand Ppt
My Brand PptMy Brand Ppt
My Brand Ppt
 
Strategic Marketing & Planning
Strategic Marketing & PlanningStrategic Marketing & Planning
Strategic Marketing & Planning
 
Shield Imc presentation
Shield Imc presentationShield Imc presentation
Shield Imc presentation
 
Copywriting
CopywritingCopywriting
Copywriting
 

IBF final presentation

  • 1. A Comparison of Ratios Of Ferozsons Lab. Ltd and Searle Pakistan Ltd . Group members Farheen Khalid Nissa Razzak Sobia Yousuf Lubna Mahar
  • 3. COMPANY PROFILE Exchanges: Karachi, Lahore & Islamabad Symbol: Feroz Country: Pakistan City: Rawalpindi Industry: The company is primarily engaged in the manufacturing and sale of pharmaceuticals and soap products Number of Employees: 461 Year Ended: 30th June
  • 5. COMPANY PROFILE Exchanges: Karachi & Islamabad Symbol: Searl Country: Pakistan City: Karachi Industry: The company is principally engaged in the manufacture of pharmaceutical products and a low calories sweetener Number of Employees: 528 Year Ended: 30th June
  • 8. CURRENT RATIO Current Ratio= Current Assets Current Liabilities 1.22 2.82 2005 1.11 2.01 2004 Searle Ferozsons Year
  • 9. QUICK RATIO (ACID-TEST RATIO) Quick Ratio= Current Asset-Inventory Current Liabilities 0.96 1.01 2005 0.97 1.89 2004 Searle Ferozsons Year
  • 11. DEBT TO EQUITY RATIO Debt-to-Equity= Total Debt Shareholder Equity 2 0.36 2005 3 0.46 2004 Searle Ferozsons Year
  • 12. DEBT TO TOTAL ASSETS Total Debt Ratio= Total Debt Total Assets 0.56 0.24 2005 0.52 0.27 2004 Searle Ferozsons Year
  • 13. EQUITY MULTIPLIER Equity Multiplier= Total Assets Shareholders’ equity 3.55 1.5 2005 4.55 1.71 2004 Searle Ferozsons Year
  • 15. TIMES INTEREST EARNED Times Interest Earned= EBIT Interest Charges 4.5 118 2005 3.9 104.5 2004 Searle Ferozsons Year
  • 17. RECEIVABLE TURNOVER Receivable Turnover= Annual Net Credit Sales Receivables 3.07 87 2005 2.8 64.5 2004 Searle Ferozsons Year
  • 18. RECEIVABLE TUROVER IN DAYS Average collection period= Days in a year Receivable Turnover 117 4 2005 129 6 2004 Searle Ferozsons Year
  • 19. INVENTORY TURNOVER Inventory Turnover = Cost Of Goods Sold Inventory 6.4 3.6 2005 5.45 3.5 2004 Searle Ferozsons Year
  • 20. INVENTORY TURNOVER IN DAYS Inventory Turnover in Days= Days in a year Inventory turnover 56 101 2005 66 103 2004 Searle Ferozsons Year
  • 21. TOTAL ASSET TURNOVER Total Asset Turnover= Net sales Total assets 1.04 1.27 2005 0.93 1.53 2004 Searle Ferozsons Year
  • 23. GROSS PROFIT MARGIN Gross Profit Margin= Gross Profit Net Sales 32.5% 53% 2005 37% 50% 2004 Searle Ferozsons Year
  • 24. NET PROFIT MARGIN Net Profit Margin= Net profit after taxes Net sales 3.50% 21% 2005 6% 16% 2004 Searle Ferozsons Year
  • 25. RETURN ON ASSETS Return on Assets= Net profit after taxes Total assets 3.70% 27% 2005 5% 24% 2004 Searle Ferozsons Year
  • 26. RETURN ON ASSETS DUPONT APPROACH Return on Assets= Net profit margin*Total Asset Turnover 0.036 0.26 2005 0.055 0.24 2004 Searle Ferozsons Year
  • 27. RETURN ON EQUITY Return on Equity= Net profit after taxes Shareholder’s equity 13.10% 41% 2005 24% 42% 2004 Searle Ferozsons Year
  • 28. RETURN ON EQUITY DUPONT APPROACH Return on Equity = Net profit margin*Total Asset Turnover*Equity Multiplier 0.13 0.40 2005 0.25 0.41 2004 Searle Ferozsons Year
  • 29. MARKET VALUE MEASURES
  • 30. EARNINGS PER SHARE EARNING PER SHARE= EAT No. Of Shares 3.6 19.87 2005 5.06 13.06 2004 Searle Ferozsons Year
  • 31. PRICE TO EARNINGS SHARE Price to Earnings Ratio= Price Earnings 11.56 9.30 2005 6.92 9.47 2004 Searle Ferozsons Year
  • 32. Common Size & Indexed Size Balance Sheet & Income Statement
  • 33. FEROZSONS’ COMMON & INDEXED SIZE BALANCE SHEET (ASSET SIDE) 72.16 100.00 100.00 100.00 575305163 415130035 TOTAL 60.19 100.00 53.19 44.37 306002950 184183116 TOTAL CURRENT ASSETS 56.74 100.00 14.44 11.35 83045347 47119395 Cash and bank balances 43.39 100.00 9.92 5.97 57071000 24763787 short term investments 54.83 100.00 1.08 0.82 6206514 3403035 Trade deposits 117.42 100.00 1.46 2.38 8415508 9881645 Trade debts (RECEIVABLES) 90.49 100.00 17.48 21.92 100545997 90984280 Stocks-in-trade 116.6  100.00 46.81 55.63 269302213 230946919 TOTAL FIXED ASSETS 100.58 100.00 0.09 0.13 538147 541247 LONG TERM DEPOSITS 100.00 100.00 0.01 0.01 33085 33085 LONG TERM INVESTMENTS 85.73 100.00 46.71 55.49 268730981 230372587 Property, plant & equipment             Fixed Assets Tangible Indexed size % Common size % Regular Years   2005 2004 2005 2004 2005 2004  
  • 34. FEROZSONS’ COMMON & INDEXED SIZE BALANCE SHEET (LIABILITY SIDE) 138.58 100.00 100.00 100.00 575305163 415130035 TOTAL LIABILITY AND EQUITY 123.26 100.00 23.80 26.76 136906815 111075514 Total liabilities 118.58 100.00 18.86 22.05 108520915 91519724   Total Current Liabilities 139.96 100.00 12.50 12.38 71912416 51381311 Trade and other payables             Current Liabilities 145.15 100.00 4.93 4.71 28385900 19555790   Total Non Current Liabilities 158.15 100.00 66.66 58.41 383470795 242479041   Total Equity Indexed Size% Common Size% Regular Years 2005 2004 2005 2004 2005 2004  
  • 35. FEROZSONS’COMMON & INDEXED SIZE INCOME SHEET 152.11 100.00 21.03 15.84 153565799 100955403 Net profit 152.31 100.00 21.05 15.83 153664442 100891537 Profit after taxes 131.50 100.00 8.71 7.59 63607622 48371149 Profit for taxation 145.56 100.00 29.76 23.41 217272064 149262686 Earning after interest 128.62 100.00 0.25 0.23 1854323 1441689 Finance Cost 145.40 100.00 30.01 23.64 219126387 150704375 EBIT 461.44 100.00 3.55 0.88 25929235 5619173 Other income 136.65 100.00 28.96 24.27 211392190 154698493 Operating profit 107.61 100.00 24.22 25.78 176837384 164335764 total expenses 104.28 100.00 19.54 21.46 142663053 136807554 selling & distribution costs 124.14 100.00 4.68 4.32 34174331 27528210 Administrative Expenses 121.69 100.00 53.18 50.05 388229574 319034257 Gross profit 107.35 100.00 46.82 49.95 341837087 318441195 Cost of goods sold 114.52 100.00 100.00 100.00 730066661 637475452 Net sales 2005 2004 2005 2004 2005 2004   Indexed Size% Common Size% Regular Year  
  • 36.
  • 37.